Suchergebnisse - "Yarnold, Paul R"

PubPharm (173)

1

Iohexol-measured glomerular filtration rate and urinary biomarker changes between vancomycin and vancomycin plus piperacillin-tazobactam in a translational rat model

enthalten in: bioRxiv.org | 2024

von Chang, J. | Pais, G. | Marianski, S. | +6

2

Individual meropenem epithelial lining fluid and plasma PK/PD target attainment

enthalten in: Antimicrobial agents and chemotherapy | 2023

von Rohani, R. | Yarnold, P. | Scheetz, M. | +12

3

Iohexol-measured glomerular filtration rate and urinary biomarker changes between vancomycin and vancomycin plus piperacillin-tazobactam in a translational rat model

enthalten in: bioRxiv : the preprint server for biology | 2023

von Chang, J. | Pais, G. | Marianski, S. | +6

UpdateIn: Antimicrob Agents Chemother. 2023 Jul 10;:e0030423. - PMID 37428202

4

Machine Learning To Stratify Methicillin-Resistant Staphylococcus aureus Risk among Hospitalized Patients with Community-Acquired Pneumonia

enthalten in: Antimicrobial agents and chemotherapy | 2023

von Rhodes, N. | Rohani, R. | Yarnold, P. | +6

5

Re : 'Limitations of classification and regression tree analysis in vancomycin exposure - response relationship studies' by Dalton et al

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2021

von Rhodes, N. | Yarnold, P.

CommentOn: Clin Microbiol Infect. 2021 Nov;27(11):1701-1703. - PMID 34332108

6

Antimicrobial never events : Objective application of a framework to assess vancomycin appropriateness

enthalten in: Infection control and hospital epidemiology | 2021

von Liu, J. | Mercuro, N. | Davis, S. | +7

7

The First 2 Years of Biosimilar Epoetin for Cancer and Chemotherapy-Induced Anemia in the U.S. : A Review from the Southern Network on Adverse Reactions

enthalten in: The oncologist | 2021

von Bennett, C. | Nagai, S. | Bennett, A. | +20

8

Characterizing Risk Factors for Clostridioides difficile Infection among Hospitalized Patients with Community-Acquired Pneumonia

enthalten in: Antimicrobial agents and chemotherapy | 2021

von Rhodes, N. | Jozefczyk, C. | Moore, W. | +8

9

Decision models to improve healthcare-associated C. difficile PCR test use in patients with community-acquired pneumonia

enthalten in: bioRxiv.org | 2021

von Rhodes, N. | Jozefczyk, C. | Moore, W. | +7

10

Consequences to patients, clinicians, and manufacturers when very serious adverse drug reactions are identified (1997-2019) : A qualitative analysis from the Southern Network on Adverse Reactions (SONAR)

enthalten in: EClinicalMedicine | 2021

von Bennett, C. | Hoque, S. | Olivieri, N. | +32

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[18]